Eli Lilly and Company

Data Analyst

Bengaluru, Karnataka, India

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
HealthcareIndustries

Requirements

Candidates must possess a Bachelor's or Master's degree in a quantitative discipline such as Finance, Econometrics, Statistics, Engineering, or Computer Sciences. Required technical skills include expertise in writing and debugging efficient SQL queries and strong experience with data visualization tools like Power BI or Tableau, with a preference for Power BI. Advanced MS-Office skills, particularly in MS-Excel and MS-PowerPoint, are also necessary. Beneficial skills include experience with R or Python. The role requires at least 7-9 years of evolving experience in data management, pharma market intelligence, performance reporting/visualization, and/or descriptive analytics, with a proven ability to understand, structure, and analyze complex datasets. Experience with project management software and proficiency in PC applications and diagramming tools like Microsoft Project, Visio, or Lucid Chart are preferred. Strong work ethic, personal motivation, interpersonal and communication skills, stakeholder management skills, and the ability to work effectively in an international matrix environment are essential.

Responsibilities

The Data Analyst will deliver key tools, data analyses, and reports to support business decisions for the integrated global medical information team. This role will champion the self-service reporting strategy and play a key part in automating and creating scalable frameworks for reporting and analytics. Responsibilities include understanding data sources used by the GMI function and Medical Contact Centers globally, building expertise on available datasets, and supporting data-enabled decision-making through the development of data lakes, insights, reporting, and visualization. The analyst will execute and monitor operations tasks to ensure the timely availability of data in reporting/dashboard structures, perform data validations to ensure data quality, respond to internal stakeholder queries, meet operations SLAs, and perform incident resolution and root cause analysis. Key duties also involve the consistent delivery of high-quality, timely, and insightful reports, developing and publishing execution dashboards according to business roadmaps and requirements, and performing descriptive analytics and visualization to provide data-driven actionable insights on planning, execution, and outcomes. Additionally, the role involves gathering requirements and providing recommendations for an integrated, real-time data analysis platform, demonstrating a deep understanding of information and material flows, processes, procedures, systems, and methods, as well as understanding internal business partners' people, processes, and technology. Collaboration with other site-level teams to identify synergies and implement best practices is also a core responsibility.

Skills

Data Analysis
Reporting
Data Visualization
Data Validation
SQL
Business Intelligence
Problem-Solving
Stakeholder Management

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI